Pharma & Biotech

BioNTech Enters Multi-Year Strategic Partnership with Victoria, Australia, to Boost Local mRNA Ecosystem

(IN BRIEF) BioNTech, a leading biotechnology company, has formalized a multi-year strategic partnership with the State of Victoria in Australia,…

2 years ago

Sanofi’s Robust Pipeline and Strategic Focus Aim to Lead Immunology Industry

(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under…

2 years ago

Sarclisa Combination Treatment Shows Promise in Phase 3 Trial for Newly Diagnosed Multiple Myeloma Patients

(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and…

2 years ago

Roche to Acquire Carmot Therapeutics for USD 2.7 Billion, Expanding Its Portfolio in Obesity Treatment

(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned…

2 years ago

Sanofi’s CHC Launches Shared Care Collective with Global Experts to Advance Health and Sustainability Initiatives

(IN BRIEF) Sanofi's Consumer Healthcare business unit (CHC) has introduced the Shared Care Collective, an advisory board consisting of experts…

2 years ago

Krka Receives TOP Education Management Certificate for Investment in Employee Development

(IN BRIEF) Krka, a Slovenian pharmaceutical company, has been honored with the TOP Education Management certificate at the Edutainment 2023…

2 years ago

AstraZeneca Showcases Hematology Advancements and Calquence’s Long-Term Efficacy at ASH Annual Meeting

(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting…

2 years ago

Novartis Outlines ‘Pure Play’ Innovative Medicines Strategy and Focused R&D Pipeline at London Event

(IN BRIEF) Novartis, a leading pharmaceutical company, presented its 'pure play' innovative medicines strategy and focused Research and Development (R&D)…

2 years ago

Boehringer Ingelheim Leverages IBM’s AI Tech for Novel Antibody Development

(IN BRIEF) Boehringer Ingelheim and IBM have formed a partnership to expedite the discovery of novel candidate antibodies for therapeutic…

2 years ago